ROYCE & ASSOCIATES LP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 143 filers reported holding ANI PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$34,000
+17.2%
1,036
+47.4%
0.00%
Q1 2020$29,000
-14.7%
703
+25.8%
0.00%
Q4 2019$34,000
-10.5%
559
+8.5%
0.00%
Q3 2019$38,000
+40.7%
515
+55.1%
0.00%
Q2 2019$27,000
-3.6%
332
-15.7%
0.00%
Q1 2019$28,000
+75.0%
394
+13.9%
0.00%
Q4 2018$16,000
-30.4%
346
-14.4%
0.00%
Q3 2018$23,0004040.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 200,000$13,270,00021.02%
Healthcare Value Capital, LLC 50,000$3,318,0005.26%
Consonance Capital Management LP 653,258$43,344,0004.17%
1492 Capital Management LLC 34,500$2,289,0001.87%
JW Asset Management, LLC 29,722$1,972,0001.36%
FRANKLIN STREET ADVISORS INC /NC 29,000$1,924,0000.35%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 55,705$3,696,0000.27%
Ativo Capital Management LLC 15,805$1,049,0000.24%
DIKER MANAGEMENT LLC 9,810$651,0000.23%
CASTLEARK MANAGEMENT LLC 100,615$6,676,0000.20%
View complete list of ANI PHARMACEUTICALS INC shareholders